This content is only available within our institutional offering.
21 Nov 2019
NOVO NORDISK: Aspiration 2025 missed the target in our view | NEUTRAL | DKK368 vs. DKK365 (0%)
Sign in
This content is only available to commercial clients. Sign in if you have access or contact support@research-tree.com to set up a commercial account
This content is only available to commercial clients. Sign in if you have access or contact support@research-tree.com to set up a commercial account
NOVO NORDISK: Aspiration 2025 missed the target in our view | NEUTRAL | DKK368 vs. DKK365 (0%)
Novo Nordisk A/S Class B (NNO2:WBO) | 0 0 2.2% | Mkt Cap: 611,927m
- Published:
21 Nov 2019 -
Author:
Eric Le Berrigaud -
Pages:
3
NOVO NORDISK - NEUTRAL | DKK368 vs. DKK365 (0%)
Aspiration 2025 missed the target in our view
Unintended key take-away message: flat margins towards 2025
NN strongly focused on the sustainability of its top-line growth
IO will drive growth
Cut in numbers over 2020-2021